Septerna
The role is a contracted 20-30 hour per week position for six months, focused on conducting in vivo rodent pharmacology studies and supporting preclinical drug discovery efforts. The candidate will work both independently and collaboratively in the Translational Sciences Department to generate data on therapeutic mechanisms, efficacy, and PK/PD relationships, with occasional weekend work.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Septerna is a biotechnology company developing GPCR-targeted medicines using its Native Complex Platform to discover and advance innovative therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Septerna.
21% above the average for this role
Analysts Conflicted on These Technology Names: Fortinet (FTNT), Septerna, Inc. (SEPN) and Oracle (ORCL)
4 days ago
Preclinical PK/PD Modeler / Quantitative Pharmacology Scientist
Ridgeline Discovery GmbH
Scientist, In Vivo Pharmacology
Flagship Pioneering, Inc.
Scientist IV Pharmacology Contractor
Qpex Biopharma
Senior Scientist I
Exelixis
Scientist, In Vivo Pharmacology
Serif
Principal Scientist, In Vivo Pharmacology, Neurology
GondolaBio Service Co, Inc.